Raising the Bar: Optimizing Outcomes With IL-23/IL-17 Inhibitors in Spondyloarthritis

Symposium

Supported By: An independent educational grant from UCB Biopharma SRL.

ACTIVITY OVERVIEW

The overall goal of treatment in spondyloarthritis (including psoriatic arthritis [PsA] and axial spondyloarthritis [axSpA]) is to optimize patient quality of life by reducing symptoms, inflammation, and structural damage. In this live symposium, expert faculty will discuss key clinical data for current and emerging therapeutic options for the management of patients with PsA and axSpA and highlight key factors that influence treatment selection for individual patients.

TARGET AUDIENCE

This activity is intended for a global audience of rheumatologists and primary care physicians.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:
Have increased knowledge regarding the

• Importance of limiting disease progression to avoid permanent disability in axSpA and PsA
• Key clinical data for interleukin (IL)-17 inhibitors in axSpA and PsA
• Demonstrate greater confidence in their ability to select an appropriate therapy for individual patients with axSpA and PsA

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Supported by an independent educational grant from UCB Biopharma SRL. This is not an official program of the American College of Rheumatology.

Speakers

​Lianne S. Gensler, MD
University of California San Francisco
Professor of Medicine
San Francisco, California

Ana-Maria Orbai, MD, MHS
Johns Hopkins University School of Medicine
Division of Rheumatology
Associate Professor
Baltimore, Maryland

Victoria Navarro Compán, MD, PhD
University Hospital La Paz and IdiPaz
Department of Rheumatology
Rheumatologist
Spain, Madrid